miRCURY LNA Power Inhibitor contr (5)

The miRCURY LNA Power Inhibitor control from QIAGEN is a research-grade antisense oligonucleotide supplied at 5 nmol scale, designed to serve as a negative control in microRNA inhibition experiments. Built on QIAGEN's locked nucleic acid (LNA) chemistry platform, this control oligonucleotide provides a baseline reference for studies that use the miRCURY LNA Power Inhibitor series to knock down specific miRNAs in mammalian cells.

Researchers typically co-transfect this control alongside target-specific inhibitors using HiPerFect Transfection Reagent or another validated delivery system, then assess inhibition efficiency by qPCR or microRNA-specific assays. The LNA-modified backbone confers high target affinity, nuclease resistance, and a Tm-normalized design that supports reproducible inhibition across cell culture models, including HeLa, A549, and many primary cell systems, supporting functional genomics, target validation, and disease-modeling workflows.

Storage at -20°C is recommended, with protection from light to preserve oligonucleotide integrity. Each vial is shipped lyophilized and is intended for research use only.